ProShare Advisors
MED icon

ProShare Advisors’s Medifast MED Stock Holding History

ProShare Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,607
Closed -$290K – 1786
2022
Q2 		$290K Sell
1,607
-953
-37% -$171K ﹤0.01% 1232
2022
Q1 		$437K Sell
2,560
-320
-11% -$60.3K ﹤0.01% 1367
2021
Q4 		$603K Buy
2,880
+1,081
+60% +$223K ﹤0.01% 1329
2021
Q3 		$347K Sell
1,799
-1,542
-46% -$379K ﹤0.01% 1441
2021
Q2 		$945K Sell
3,341
-25
-0.7% -$6.77K ﹤0.01% 1070
2021
Q1 		$713K Buy
3,366
+641
+24% +$153K ﹤0.01% 1205
2020
Q4 		$535K Buy
2,725
+1,126
+70% +$199K ﹤0.01% 1230
2020
Q3 		$263K Sell
1,599
-133
-8% -$21.9K ﹤0.01% 1269
2020
Q2 		$240K Buy
+1,732
New +$159K ﹤0.01% 1359
2020
Q1 		– Sell
-1,821
Closed -$200K – 1416
2019
Q4 		$200K Buy
+1,821
New +$176K ﹤0.01% 1594
2019
Q3 		– Sell
-1,581
Closed -$203K – 1677
2019
Q2 		$203K Sell
1,581
-33
-2% -$4.58K ﹤0.01% 1434
2019
Q1 		$206K Buy
+1,614
New +$205K ﹤0.01% 1460
2018
Q4 		– Sell
-1,733
Closed -$384K – 1650
2018
Q3 		$384K Sell
1,733
-150
-8% -$30.4K ﹤0.01% 1230
2018
Q2 		$302K Buy
+1,883
New +$241K ﹤0.01% 1386
2014
Q3 		– Sell
-6,883
Closed -$209K – 2338
2014
Q2 		$209K Sell
6,883
-7,374
-52% -$230K ﹤0.01% 2146
2014
Q1 		$415K Buy
+14,257
New +$382K 0.01% 2010
2013
Q4 		– Sell
-8,998
Closed -$242K – 1638
2013
Q3 		$242K Buy
8,998
+518
+6% +$13.9K 0.01% 2063
2013
Q2 		$218K Buy
+8,480
New +$223K ﹤0.01% 1965

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ProShare Advisors's MED Position: Q3 2022 in Review

ProShare Advisors sold out of Medifast (MED) in Q3 2022, closing a stake of 1,607 shares — an estimated $290K sold.

ProShare Advisors first reported a position in MED in Q2 2013 and held it in 18 quarters. The position peaked at $945K in Q2 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • ProShare Advisors reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • ProShare Advisors sold 1,607 Medifast shares in Q3 2022, an estimated $290K.
  • ProShare Advisors first reported a position in Medifast in Q2 2013 and held it in 18 quarters.
  • ProShare Advisors's Medifast position peaked at $945K in Q2 2021.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.